Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

Clinical trial NCT04628026 · RECRUITING

Trial details

NCT number

NCT04628026

Sponsor

University of Ulm

Status

RECRUITING

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2022-09-13

Primary completion

2029-03-01

Enrollment

650

View on ClinicalTrials.gov